{'fraction_non_alphanumeric': 0.02208835341365462, 'fraction_numerical': 0.019076305220883535, 'mean_word_length': 5.192546583850931, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The Placental Transfer of Pancuronium and its Pharmacokinetics During Caesarian Section

The placental transfer of pancuronium and its pharmacokinetics were investigated in 33 pregnant women undergoing caesarean section. After a single intravenous injection of 60–100 μg/kg, the serum pancuronium concentration was measured (using a fluorimetric method) in serial samples of maternal blood and in umbilical arterial and venous blood obtained at the time of delivery. Detectable amounts of pancuronium were found in all foetal blood samples. The cord vein to maternal concentration ratio of pancuronium averaged 0.22; it increased significantly with prolongation of the induction‐delivery interval. The mean cord arterial to cord venous ratio of pancuronium was 0.66 (range 0.2–1.0), suggesting foetal drug uptake. Apgar scores were above 9 at 5 min in all cases, and there was no clinical evidence of any adverse effect in the newborns which could be related to the presence of a muscle relaxant.